15 min listen
Latest therapies in AML: IMGN632, magrolimab & gilteritinib
FromVJHemOnc Podcast
ratings:
Length:
13 minutes
Released:
Mar 16, 2021
Format:
Podcast episode
Description
The armamentarium of therapeutic modalities in acute myeloid leukemia (AML) has taken several strides in the last few years as...
The post Latest therapies in AML: IMGN632, magrolimab & gilteritinib appeared first on VJHemOnc.
The post Latest therapies in AML: IMGN632, magrolimab & gilteritinib appeared first on VJHemOnc.
Released:
Mar 16, 2021
Format:
Podcast episode
Titles in the series (100)
Acute leukemias discussion: what does genomics and epigenomics tell us about patient management?: A stimulating session on the implications of genomic data for the management of acute myeloid leukemia (AML) and acute lymphoblastic... by VJHemOnc Podcast